BAA FY26C1FP7 MD anderson oncology center for excellence (OCE), evaluating bayesian effective sample size and decision criteria for pediatric and rare disease trials
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00055
- Awardee
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $752,304
Award facts
- Contract value 100% obligated
- $752,304.00 Current and potential, with all options
- Completion date 2% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Houston, TX 77030, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $752,304 definitive contract to The University of Texas M.D. Anderson Cancer Center for evaluating Bayesian effective sample size and decision criteria for pediatric and rare disease trials on September 30, 2026, under a firm fixed-price structure with no set-aside.
Place of performance is Houston, TX. The contract runs through September 29, 2028. The originating solicitation references BAA FY26C1FP7 MD Anderson Oncology Center for Excellence (OCE), focused on statistical methodology development to support regulatory decision-making in pediatric and rare disease trial design, leveraging MD Anderson's research infrastructure in cancer clinical trials and biostatistical innovation.
Quick answers
Who was awarded contract 75F40126C00055?
75F40126C00055 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00055 worth?
The government has obligated $752,304 on 75F40126C00055.
Was contract 75F40126C00055 competed?
The extent of competition for 75F40126C00055 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award